Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check34 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new release/version update.SummaryDifference0.3%

- Check48 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' link has been removed, representing a minor UI change.SummaryDifference0.7%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.7%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference11%

- Check77 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.